Interesting tidbits from the investor callWith the intergation of Insig, WELL's B2C app going forward will be Tia Health (but VC+ will remain but as part of the SaaS offering to doctors. As some know, Insig is part of Rexall's core telemedicine offering (Under Tia Health brand) as well as for Canada's most extensive chain of clinincs, Appletree (under Insig brand). So now all revenue from Insig will stay within WELL rather than splitting 50-50. BTW, Insig reports that latest stats show that 50% are repeat customers (forming attachments).
Anyone else listen in and can add other insights?